Detailed Information on Publication Record
2022
Hepatitis E - epidemiology and clinical course in the largest cohort in the Czech Republic.
MIHALČIN, Matúš, Libuše HUSOVÁ, Petra VAŠÍČKOVÁ, Marcel BENA, Petr HUSA et. al.Basic information
Original name
Hepatitis E - epidemiology and clinical course in the largest cohort in the Czech Republic.
Authors
MIHALČIN, Matúš (703 Slovakia, guarantor, belonging to the institution), Libuše HUSOVÁ (203 Czech Republic), Petra VAŠÍČKOVÁ (203 Czech Republic), Marcel BENA and Petr HUSA (203 Czech Republic, belonging to the institution)
Edition
Archives of Medical Science, Poland, Termedia Publishing House, 2022, 1734-1922
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30218 General and internal medicine
Country of publisher
Poland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.800
RIV identification code
RIV/00216224:14110/22:00126979
Organization unit
Faculty of Medicine
UT WoS
000869187900028
Keywords in English
therapy; epidemiology; Czech Republic; Eastern Europe; hepatitis E; hepatitis E virus; viral zoonosis
Tags
International impact, Reviewed
Změněno: 7/11/2022 08:12, Mgr. Tereza Miškechová
Abstract
V originále
Introduction: The majority of hepatitis E (HE) reports come from Western Europe. The aim of the study was to describe the typical epidemiological and clinical characteristics of HE in the Czech Republic. Material and methods: The retrospective analysis of 173 patients with HE. Results: At least 90% of cases were autochthonous (HEV-3 genotype). Seventeen patients were treated with ribavirin. Five underwent liver transplants because of fulminant HE. We noted neurological symptomatology in 9 cases. Six patients developed chronic HE. Conclusions: There is a possibility of severe health complications caused by the hepatitis E virus in the Czech Republic.